Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells.

Takahashi A, Umemura A, Yano K, Okishio S and 6 more